Harbour Investments, Inc. Ardelyx, Inc. Transaction History
Harbour Investments, Inc.
- $3.14 Billion
- Q3 2024
A detailed history of Harbour Investments, Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 700 shares of ARDX stock, worth $4,053. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700
Previous 700
-0.0%
Holding current value
$4,053
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
210Shares Held
144MCall Options Held
1.01MPut Options Held
1.43M-
Janus Henderson Group PLC London, X025.9MShares$150 Million0.11% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$102 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$79.1 Million0.0% of portfolio
-
State Street Corp Boston, MA12MShares$69.3 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C36.9MShares$40 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $895M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...